Interferon Hepatitis
Links shared publicly online about this topic
Oncology Medical News about Carcinoma Carcinoma, Hepatocellular Interferons Hepatitis C, Chronic
mdlinx.com — “Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon therapy of chronic hepatitis C” View full resource at mdlinx.com
Most Recently Shared on June 23, 2010 at 5:44 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Meta-analysis: Reduced incidence of hepatocellular carcinoma in patients not responding to interferon the... http://bit.ly/9P7UKi #oncology
Interferon and Ribavirin - The Body
thebody.com — “Approved Treatment for Hepatitis C The only treatment for hepatitis C (HCV) approved by the FDA is the combination of interferon (IFN) and ribavirin ...” View full resource at thebody.com
Most Recently Shared on April 13, 2011 at 9:01 pm By:
Interferon and Ribavirin http://bit.ly/eccsBY #hiv #aids #hepatitis #hepc #hcv
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure
medicalnewstoday.com — “According to new data from the largest Phase II interferon-free trial to date, after only 28 weeks of treatment, almost 82% of hepatitis C patients achieved a viral cure. The results were achieve” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2012 at 8:05 pm By:
Interferon-Free Hepatitis C Trial Achieves 82% Viral Cure http://t.co/PMIB5efb #healthnews
HCV New Drug Research: Hepatitis C : Ribavirin Plus Interferon vs. Interferon Monotherapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C : Ribavirin Plus Interferon vs. Interferon Monotherapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on December 14, 2010 at 4:17 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C : Ribavirin Plus Interferon vs. Interferon Monotherapy http://goo.gl/fb/D8Loz
HCV New Drug Research: Hepatitis C: Interferon-associated retinopathy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C: Interferon-associated retinopathy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on November 30, 2010 at 7:38 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
HCV New Drug Research: Hepatitis C: Interferon-associated retinopathy http://t.co/VTKuNUL
Successful short-term peg-interferon monotherapy for chronic hepatitis
physorg.com — “The standard duration of interferon therapy for chronic hepatitis C could be shortened according to the virological and clinical status of each patient. A research group in Japan proposed a new concept, 'immediate virological response (IVR)', and showed that short-term peg-interferon monotherapy was ...” View full resource at physorg.com
Most Recently Shared on April 8, 2010 at 5:11 pm By:
PhysOrg Health News Health News
Successful short-term peg-interferon monotherapy for chronic hepatitis http://tw.physorg.com/189947567
Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective
news-medical.net — “The current standard treatment for chronic hepatitis C with pegylated-interferon (PEG-IFN) and ribavirin is effective in approximately 50%-60% of patients, so that a substantial proportion of patients remain unresponsive.” View full resource at news-medical.net
Most Recently Shared on January 18, 2010 at 5:19 am By:
Treatment for chronic hepatitis C with pegylated-interferon and ribavirin proves effective: The current standard t... http://bit.ly/5ana3F
Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial Of PSI-7977 For Chronic Hepatitis C
medicalnewstoday.com — “Pharmasset, Inc. (Nasdaq: VRUS) announced that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The t” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
Pharmasset Initiates Exploratory Interferon Sparing Clinical Trial Of PSI-7977 For Chronic Hepatitis C http://mnt.to/3P6G #liver #hepatitis
Conatus Pharmaceuticals Initiates Phase II Clinical Trial In Combination With Pegylated Interferon And Ribavirin For The Treatment Of Hepatitis C
medicalnewstoday.com — “Conatus Pharmaceuticals Inc. announced the initiation of a Phase II clinical trial evaluating CTS-1027 in combination with pegylated interferon (Pegasys®) and ribavirin (Copegus®) in refra” View full resource at medicalnewstoday.com
Most Recently Shared on January 29, 2010 at 4:08 pm By:
MNT Clinical Trials Health News
Conatus Pharmaceuticals Initiates Phase II Clinical Trial In Combination With Pegylated Interferon And Ribavirin For T... http://mnt.to/3wWN
EASL: BMS PEG-Interferon Lambda Achieved Higher Response Rates Than Standard Regimen In Hepatitis C
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin” View full resource at medicalnewstoday.com
Most Recently Shared on April 4, 2011 at 11:05 am By:
EASL: BMS PEG-Interferon Lambda Achieved Higher Response Rates Than Standard Regimen In Hepatitis C http://mnt.to/3T7p #liver #hepatitis
Fluvastatin Enhances HCV Response In Combination With Interferon And Ribavirin
medicalnewstoday.com — “New data presented at the International Liver CongressTM confirm the antiviral activity of fluvastatin - commonly used as a cholesterol-lowering treatment - in patients with chronic hepatitis C (H” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2011 at 10:05 am By:
Fluvastatin Enhances HCV Response In Combination With Interferon And Ribavirin http://mnt.to/3T3L #statins
HCV New Drug Research: ASSESSMENT WITH MAINTENANCE INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: ASSESSMENT WITH MAINTENANCE INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 8, 2011 at 12:47 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
ASSESSMENT WITH MAINTENANCE INTERFERON IN PATIENTS WITH CHRONIC HEPATITIS C http://goo.gl/fb/NTIEI
HCV New Drug Research: Hepatitis C News: Was pulmonary toxicity induced by interferon therapy?
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C News: Was pulmonary toxicity induced by interferon therapy?” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 3, 2011 at 2:01 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C News: Was pulmonary toxicity induced by interferon therapy? http://goo.gl/fb/NrOz1
HCV New Drug Research: Suicide risk in hepatitis C and with interferon-alpha therapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Suicide risk in hepatitis C and with interferon-alpha therapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 6, 2011 at 3:05 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Suicide risk in hepatitis C and with interferon-alpha therapy http://goo.gl/fb/lh38z
HCV New Drug Research: Hepatitis C; Effects of interferon on development/progression of hepatocellular carcinoma
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; Effects of interferon on development/progression of hepatocellular carcinoma” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on June 30, 2011 at 11:16 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C; Effects of interferon on development/progression of hepatocellular carcinoma http://goo.gl/fb/HiriL
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
The Body
The Complete HIV/AIDS Resource.
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
Advertisement
